Fullintel

Fullintel delivers AI-powered media monitoring & PR analysis with expert insights for real-time, actionable decisions. #PR #MediaMonitoring #AI #Insights

[Fullintel @fullintel]

A crisis can erase decades of brand equity in hours. Here’s how the brands that recover actually do it: https://t.co/l4CM2xG5fD

#CrisisManagement #ReputationManagement #PR #BrandReputation #CrisisComms

[Fullintel @fullintel]

Podcasts are now a news channel. 1 in 7 Americans listen to news podcasts weekly, and most monitoring misses it.

See podcasts in your daily Executive News Brief, analyst-curated by Fullintel.

📩 Request a sample: https://t.co/Ox022nkT3U

#MediaMonitoring #Podcasts

[Fullintel @fullintel]

Fullintel is at PRSA ICON 2026.

📅 Oct 18-20
📍 Orlando World Center Marriott
🎯 Booth 110

We're bringing the first look at Fullintel OS, a week before it launches Oct 26.

Join the waitlist: https://t.co/b8mXoVyM8t

#PRSAICON #PublicRelations #MediaIntelligence

[Fullintel @fullintel]

3 @PRNews Platinum Awards 🏆, including a Platinum Elite for our research, "Getting Past the Velvet Rope."

Thank you, Angela, and the whole Fullintel team. ❤️

Read the award-winning research: https://t.co/1LDuRrrDBb

#PRMeasurement #AI #EarnedMedia

[Fullintel @fullintel]

Clip counts tell you something happened. They don't tell you what it achieved.

15 media monitoring KPIs that do: https://t.co/5hFSpKs6XW

#PRMeasurement #MediaMonitoring

[Fullintel @fullintel]

Drug-pricing deals widen. Lilly spends up to $2.88B on Merida. 200+ lawsuits hit GLP-1 makers over vision-loss claims. Our September pharma roundup breaks down what each one did to sentiment: https://t.co/6Ut26ULOhk

#Pharma #DrugPricing #GLP1

[Fullintel @fullintel]

Both submissions we entered are on the 2026 AMEC Awards winners list. 🎉

Congratulations to RWJBarnabas and IGMFinancial. Categories and levels revealed in London on Nov 5.

#AMECAwards #AMEC2026 #MediaIntelligence

[Fullintel @fullintel]

We're at @PRSA ICON 2026 as a bronze sponsor.

📅 Oct 18–20
📍 Orlando World Center Marriott
🎯 Booth 110

Javen, Kyle, and Andrew are on the floor all three days. Come say hello.

#PRSAICON

[Fullintel @fullintel]

That's a wrap on #FiercePharmaWeek! 🙌 Angela Dwyer, APR, joined the "Metrics to Meaning" PR & Comms panel in Philadelphia — measuring reputation that drives business decisions. Thanks to all who connected with us!

[Fullintel @fullintel]

Four disciplines. 11 countries. One Media Impact Score.

See how we unified measurement for a global CX software company: https://t.co/iBpTnrgQ9O

#MediaIntelligence #PRMeasurement

[Fullintel @fullintel]

Reputation you can measure. Decisions you can act on. 📊

Our VP of Insights, Angela Dwyer, APR, joins the "Metrics to Meaning" panel at #FiercePharmaWeek 2026 in Philadelphia.

🗓 Wed, Sep 16 · 4:35 PM

#ReputationManagement #PharmaPR

[Fullintel @fullintel]

~40% of long-form LinkedIn posts are now AI-generated, and flagged "slop" is losing about 40% of its reach.

#Mediamonitoring was always about signal vs noise. Now the noise writes itself. Counting mentions isn't understanding them.

Human judgment is the differentiator.

#PR

[Fullintel @fullintel]

Pharma innovation is advancing, while policy and ethics remain under scrutiny.

• Personalized cancer vaccines
• U.S. vaccine policy changes
• Gene-editing safety concerns

Explore the latest analysis: https://t.co/1Ad0vrJvRn

#Pharma #PharmaNews #Healthcare

[Fullintel @fullintel]

How much of the media conversation does your brand own?

Learn how Share of Voice helps PR teams measure visibility, track competitors, and understand the story behind the numbers.

Read more: https://t.co/534VVRmL9c

#ShareOfVoice #PR #MediaMonitoring

[Fullintel @fullintel]

Reputation isn't what people say; it's what they do.

Our VP of Insights, Angela Dwyer, APR, joins the "Metrics to Meaning" panel at #FiercePharmaWeek 2026.

📍Philadelphia · Wed, Sep 16 · 4:35 PM

Attending? Join the session & say hello 👋

[Fullintel @fullintel]

What’s shaping the pharmaceutical industry?

Medicare drug pricing, the first CAR-T therapy for solid tumors, and AI-driven healthcare innovation are among the key developments to watch.

Read more: https://t.co/q3EYb8qk9Y

#Pharma #PharmaNews #HealthcareAI

[Fullintel @fullintel]

Industry shifts show up in media coverage before they reach the numbers. Our latest blog breaks down how to spot the early signals, with generative AI as the example. https://t.co/h0uI2z70IW

#MediaMonitoring #CorporateComms

[AmecOrg @AmecOrg]

Watch Megan and fellow experts in the full #AMECAwards Tips & Tricks webinar — from methodology to messaging, get practical guidance from award-winning teams at @KetchumPR, @EdelmanPR, @Commetric and @fullintel: 🎥 https://t.co/sBPUCuVcgi

[Fullintel @fullintel]

Biotech moves fast. A missed clinical trial headline or regulatory update can tank investor trust.
Old-school monitoring won’t catch it.
Here’s what will: https://t.co/srQRdje8wZ

#MediaIntelligence #LifeSciencesComms #BiotechMediaMonitoring #PharmaPR #MediaMonitoring

[Fullintel @fullintel]

PR crises don’t wait for business hours.
They don’t send calendar invites.
And they don’t follow your comms playbook.
In 2025, #crisismonitoring needs to be real-time, global, and human-informed.
📉 Don’t just react.
📈 Stay ahead: https://t.co/fBFPCbJkUr

#PR #MediaIntelligence